Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 8/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 0.70 |
| ▸ | RAB9A | P51151 | 1/20 | 0.70 |
| ▸ | HTR7 | P34969 | 1/20 | 0.59 |
| ▸ | STS | P08842 | 4/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | DPP4 | P27487 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | ABL1 | P00519 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | ALPI | P09923 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | ALPG | P10696 | 1/20 | 0.57 |
| ▸ | APEX1 | P27695 | 1/20 | 0.57 |
| ▸ | CASP3 | P42574 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | CASP7 | P55210 | 1/20 | 0.57 |
| ▸ | CASP6 | P55212 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2720252 | 1.00 | HSD17B3 (1.00) | HSD17B3NPC1RAB9AHTR7STS | |
| SCHEMBL27878550 | 1.00 | HSD17B3 (1.00) | HSD17B3NPC1RAB9AHTR7STS | |
| SCHEMBL1751770 | 1.00 | HSD17B3 (1.00) | HSD17B3NPC1RAB9AHTR7STS | |
| SCHEMBL26133711 | 1.00 | HSD17B3 (1.00) | HSD17B3NPC1RAB9AHTR7STS | |
| SCHEMBL11567883 | 1.00 | HSD17B3 (1.00) | HSD17B3NPC1RAB9AHTR7STS | |
| SCHEMBL28560063 | 1.00 | HSD17B3 (1.00) | HSD17B3NPC1RAB9AHTR7STS | |
| SCHEMBL2082331 | 1.00 | HSD17B3 (1.00) | HSD17B3NPC1RAB9AHTR7STS | |
| SCHEMBL4776206 | 1.00 | HSD17B3 (1.00) | HSD17B3NPC1RAB9AHTR7STS | |
| SCHEMBL1919198 | 0.98 | HSD17B3 (1.00) | HSD17B3NPC1RAB9AHTR7STS | |
| SCHEMBL10586700 | 0.95 | HSD17B3 (0.90) | HSD17B3NPC1RAB9AHTR7STS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2674476-B2 | Detergent composition | PROCTER & GAMBLE (US) | 2021-11-10 | — | — | EP | claimed |
| EP-3095861-B1 | CONSUMER PRODUCTS WITH PROTEASE VARIANTS | PROCTER & GAMBLE (US) | 2019-06-26 | — | — | EP | claimed |
| EP-2674476-B1 | Detergent composition | PROCTER & GAMBLE (US) | 2018-04-18 | — | — | EP | claimed |
| CN-113646052-B | Reversible thermochromic composition, reversible thermochromic microcapsule pigment, and writing instrument | 百乐墨水株式会社 | 2024-05-17 | — | — | CN | disclosed |
| CN-113785023-B | Water-based ink composition for reversible thermochromic writing instrument, refill for refill and water-based ballpoint pen incorporating same | 株式会社百乐 | 2023-05-12 | — | — | CN | disclosed |
| CN-113785023-A | Water-based ink composition for reversible thermal discoloration writing instrument, refill containing the same, and water-based ballpoint pen | 株式会社百乐 | 2021-12-10 | — | — | CN | disclosed |
| CN-113646052-A | Reversible thermal discoloration composition, reversible thermal discoloration microcapsule pigment encapsulating the reversible thermal discoloration composition, and writing instrument using the reversible thermal discoloration microcapsule pigment | 百乐墨水株式会社 | 2021-11-12 | — | — | CN | disclosed |
| US-20130281353-A1 | Use of Metal Hydrazide Complex Compounds as Oxidation Catalysts | BASF SE (DE) | 2013-10-24 | — | — | US | disclosed |
| US-8492324-B2 | Use of metal hydrazide complex compounds as oxidation catalysts | BASF SE (DE) | 2013-07-23 | — | — | US | disclosed |
| US-20110071066-A1 | USE OF METAL HYDRAZIDE COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | BASF SE (DE) | 2011-03-24 | — | — | US | disclosed |
| US-5741821-A | PHENOLIC ENZYME INHIBITORS | THE UNIVERSITY OF SYDNEY (AU) | 1998-04-21 | — | — | US | disclosed |
| WO-1994028886-A1 | USE OF NATURAL PRODUCTS AND RELATED SYNTHETIC COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE | THE UNIVERSITY OF SYDNEY (AU) | 1994-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071066-A1 | USE OF METAL HYDRAZIDE COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | SOD1, H1-4, H1-5 | HSD17B3 3308/4885NPC1 4518/4885RAB9A 3542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.